APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Pain Medication

Compare research editions
View pricing & licenses

Selected research

Industry Research

Veterinary Pain Medication Industry Research Report 2026

20 December 2025132 pages

Choose your research edition.

Industry ResearchVeterinary Pain Medication Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Pain Medication Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Veterinary Pain Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Pain Medication Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Pain Medication Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Veterinary Pain Medication market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Veterinary Pain Medication is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Veterinary Pain Medication is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Veterinary Pain Medication is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Veterinary Pain Medication include Zoetis, Ringpu Bio-technology, Ruicheng Lvman Biological Pharmaceutical Co., Ltd., Merck & Co, Medtronic, Lilly, Pfizer, Harbin Bolai Pharmaceutical Co., Ltd. and Bostonscientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Veterinary Pain Medication market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Veterinary Pain Medication Market by Company

Zoetis

Ringpu Bio-technology

Ruicheng Lvman Biological Pharmaceutical Co., Ltd.

Merck & Co

Medtronic

Lilly

Pfizer

Harbin Bolai Pharmaceutical Co., Ltd.

Bostonscientific

Bayer Pharma AG

Baxter

Norbrook Laboratories

Halyard

Forest Laboratories

Endo International

Elanco

Ceva Sante Animale

Boehringer Ingelheim

Veterinary Pain Medication Segment by Type

Injection Medicines

Oral Medicines

Veterinary Pain Medication Segment by Application

Veterinary Hospitals

Veterinary Clinics

Others

Veterinary Pain Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Pain Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Pain Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Pain Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Veterinary Pain Medication manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Veterinary Pain Medication by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Veterinary Pain Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Veterinary Pain Medication Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Veterinary Pain Medication Sales (k units) of Manufacturers (2021-2026) Table 7. Global Veterinary Pain Medication Sales Market Share by Manufacturers (2021-2026) Table 8. Global Veterinary Pain Medication Revenue of Manufacturers (2021-2026) Table 9. Global Veterinary Pain Medication Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Veterinary Pain Medication Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Veterinary Pain Medication Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Veterinary Pain Medication, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Veterinary Pain Medication, Product Type & Application Table 14. Global Veterinary Pain Medication Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Veterinary Pain Medication by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zoetis Company Information Table 19. Zoetis Business Overview Table 20. Zoetis Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Zoetis Veterinary Pain Medication Product Portfolio Table 22. Zoetis Recent Developments Table 23. Ringpu Bio-technology Company Information Table 24. Ringpu Bio-technology Business Overview Table 25. Ringpu Bio-technology Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Ringpu Bio-technology Veterinary Pain Medication Product Portfolio Table 27. Ringpu Bio-technology Recent Developments Table 28. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Company Information Table 29. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Business Overview Table 30. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio Table 32. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Recent Developments Table 33. Merck & Co Company Information Table 34. Merck & Co Business Overview Table 35. Merck & Co Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Merck & Co Veterinary Pain Medication Product Portfolio Table 37. Merck & Co Recent Developments Table 38. Medtronic Company Information Table 39. Medtronic Business Overview Table 40. Medtronic Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Medtronic Veterinary Pain Medication Product Portfolio Table 42. Medtronic Recent Developments Table 43. Lilly Company Information Table 44. Lilly Business Overview Table 45. Lilly Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Lilly Veterinary Pain Medication Product Portfolio Table 47. Lilly Recent Developments Table 48. Pfizer Company Information Table 49. Pfizer Business Overview Table 50. Pfizer Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Pfizer Veterinary Pain Medication Product Portfolio Table 52. Pfizer Recent Developments Table 53. Harbin Bolai Pharmaceutical Co., Ltd. Company Information Table 54. Harbin Bolai Pharmaceutical Co., Ltd. Business Overview Table 55. Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio Table 57. Harbin Bolai Pharmaceutical Co., Ltd. Recent Developments Table 58. Bostonscientific Company Information Table 59. Bostonscientific Business Overview Table 60. Bostonscientific Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Bostonscientific Veterinary Pain Medication Product Portfolio Table 62. Bostonscientific Recent Developments Table 63. Bayer Pharma AG Company Information Table 64. Bayer Pharma AG Business Overview Table 65. Bayer Pharma AG Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Bayer Pharma AG Veterinary Pain Medication Product Portfolio Table 67. Bayer Pharma AG Recent Developments Table 68. Baxter Company Information Table 69. Baxter Business Overview Table 70. Baxter Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Baxter Veterinary Pain Medication Product Portfolio Table 72. Baxter Recent Developments Table 73. Norbrook Laboratories Company Information Table 74. Norbrook Laboratories Business Overview Table 75. Norbrook Laboratories Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Norbrook Laboratories Veterinary Pain Medication Product Portfolio Table 77. Norbrook Laboratories Recent Developments Table 78. Halyard Company Information Table 79. Halyard Business Overview Table 80. Halyard Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Halyard Veterinary Pain Medication Product Portfolio Table 82. Halyard Recent Developments Table 83. Forest Laboratories Company Information Table 84. Forest Laboratories Business Overview Table 85. Forest Laboratories Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Forest Laboratories Veterinary Pain Medication Product Portfolio Table 87. Forest Laboratories Recent Developments Table 88. Endo International Company Information Table 89. Endo International Business Overview Table 90. Endo International Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Endo International Veterinary Pain Medication Product Portfolio Table 92. Endo International Recent Developments Table 93. Elanco Company Information Table 94. Elanco Business Overview Table 95. Elanco Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Elanco Veterinary Pain Medication Product Portfolio Table 97. Elanco Recent Developments Table 98. Ceva Sante Animale Company Information Table 99. Ceva Sante Animale Business Overview Table 100. Ceva Sante Animale Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Ceva Sante Animale Veterinary Pain Medication Product Portfolio Table 102. Ceva Sante Animale Recent Developments Table 103. Boehringer Ingelheim Company Information Table 104. Boehringer Ingelheim Business Overview Table 105. Boehringer Ingelheim Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Boehringer Ingelheim Veterinary Pain Medication Product Portfolio Table 107. Boehringer Ingelheim Recent Developments Table 108. Global Veterinary Pain Medication Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Veterinary Pain Medication Sales by Region (2021-2026) & (k units) Table 110. Global Veterinary Pain Medication Sales Market Share by Region (2021-2026) Table 111. Global Veterinary Pain Medication Sales by Region (2027-2032) & (k units) Table 112. Global Veterinary Pain Medication Sales Market Share by Region (2027-2032) Table 113. Global Veterinary Pain Medication Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Veterinary Pain Medication Revenue Market Share by Region (2021-2026) Table 115. Global Veterinary Pain Medication Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Veterinary Pain Medication Revenue Market Share by Region (2027-2032) Table 117. North America Veterinary Pain Medication Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Veterinary Pain Medication Sales by Country (2021-2026) & (k units) Table 119. North America Veterinary Pain Medication Sales by Country (2027-2032) & (k units) Table 120. North America Veterinary Pain Medication Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Veterinary Pain Medication Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Veterinary Pain Medication Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Veterinary Pain Medication Sales by Country (2021-2026) & (k units) Table 124. Europe Veterinary Pain Medication Sales by Country (2027-2032) & (k units) Table 125. Europe Veterinary Pain Medication Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Veterinary Pain Medication Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Veterinary Pain Medication Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Veterinary Pain Medication Sales by Country (2021-2026) & (k units) Table 129. Asia Pacific Veterinary Pain Medication Sales by Country (2027-2032) & (k units) Table 130. Asia Pacific Veterinary Pain Medication Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Veterinary Pain Medication Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Veterinary Pain Medication Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Veterinary Pain Medication Sales by Country (2021-2026) & (k units) Table 134. South America Veterinary Pain Medication Sales by Country (2027-2032) & (k units) Table 135. South America Veterinary Pain Medication Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Veterinary Pain Medication Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Veterinary Pain Medication Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Veterinary Pain Medication Sales by Country (2021-2026) & (k units) Table 139. Middle East and Africa Veterinary Pain Medication Sales by Country (2027-2032) & (k units) Table 140. Middle East and Africa Veterinary Pain Medication Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Veterinary Pain Medication Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Veterinary Pain Medication Sales by Type (2021-2026) & (k units) Table 143. Global Veterinary Pain Medication Sales by Type (2027-2032) & (k units) Table 144. Global Veterinary Pain Medication Sales Market Share by Type (2021-2026) Table 145. Global Veterinary Pain Medication Sales Market Share by Type (2027-2032) Table 146. Global Veterinary Pain Medication Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Veterinary Pain Medication Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Veterinary Pain Medication Revenue Market Share by Type (2021-2026) Table 149. Global Veterinary Pain Medication Revenue Market Share by Type (2027-2032) Table 150. Global Veterinary Pain Medication Price by Type (2021-2026) & (US$/unit) Table 151. Global Veterinary Pain Medication Price by Type (2027-2032) & (US$/unit) Table 152. Global Veterinary Pain Medication Sales by Application (2021-2026) & (k units) Table 153. Global Veterinary Pain Medication Sales by Application (2027-2032) & (k units) Table 154. Global Veterinary Pain Medication Sales Market Share by Application (2021-2026) Table 155. Global Veterinary Pain Medication Sales Market Share by Application (2027-2032) Table 156. Global Veterinary Pain Medication Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Veterinary Pain Medication Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Veterinary Pain Medication Revenue Market Share by Application (2021-2026) Table 159. Global Veterinary Pain Medication Revenue Market Share by Application (2027-2032) Table 160. Global Veterinary Pain Medication Price by Application (2021-2026) & (US$/unit) Table 161. Global Veterinary Pain Medication Price by Application (2027-2032) & (US$/unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Veterinary Pain Medication Distributors List Table 165. Veterinary Pain Medication Customers List Table 166. Veterinary Pain Medication Industry Trends Table 167. Veterinary Pain Medication Industry Drivers Table 168. Veterinary Pain Medication Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Veterinary Pain Medication Product Image Figure 5. Global Veterinary Pain Medication Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Veterinary Pain Medication Market Size (2021-2032) & (US$ Million) Figure 7. Global Veterinary Pain Medication Sales (2021-2032) & (k units) Figure 8. Global Veterinary Pain Medication Average Price (US$/unit) & (2021-2032) Figure 9. Injection Medicines Product Image Figure 10. Oral Medicines Product Image Figure 11. Veterinary Hospitals Product Image Figure 12. Veterinary Clinics Product Image Figure 13. Others Product Image Figure 14. Global Veterinary Pain Medication Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Veterinary Pain Medication, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Veterinary Pain Medication Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Veterinary Pain Medication Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Veterinary Pain Medication Sales by Region in 2025 Figure 20. Global Veterinary Pain Medication Revenue by Region in 2025 Figure 21. North America Veterinary Pain Medication Market Size by Country in 2025 Figure 22. North America Veterinary Pain Medication Sales Market Share by Country (2021-2032) Figure 23. North America Veterinary Pain Medication Revenue Market Share by Country (2021-2032) Figure 24. United States Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Veterinary Pain Medication Market Size by Country in 2025 Figure 28. Europe Veterinary Pain Medication Sales Market Share by Country (2021-2032) Figure 29. Europe Veterinary Pain Medication Revenue Market Share by Country (2021-2032) Figure 30. Germany Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Veterinary Pain Medication Market Size by Country in 2025 Figure 41. Asia Pacific Veterinary Pain Medication Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Veterinary Pain Medication Revenue Market Share by Country (2021-2032) Figure 43. China Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Veterinary Pain Medication Market Size by Country in 2025 Figure 52. South America Veterinary Pain Medication Sales Market Share by Country (2021-2032) Figure 53. South America Veterinary Pain Medication Revenue Market Share by Country (2021-2032) Figure 54. Brazil Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Veterinary Pain Medication Market Size by Country in 2025 Figure 58. Middle East and Africa Veterinary Pain Medication Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Veterinary Pain Medication Revenue Market Share by Country (2021-2032) Figure 60. Egypt Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Veterinary Pain Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Veterinary Pain Medication Sales Market Share by Type (2021-2032) Figure 66. Global Veterinary Pain Medication Revenue Market Share by Type (2021-2032) Figure 67. Global Veterinary Pain Medication Price (US$/unit) by Type (2021-2032) Figure 68. Global Veterinary Pain Medication Sales Market Share by Application (2021-2032) Figure 69. Global Veterinary Pain Medication Revenue Market Share by Application (2021-2032) Figure 70. Global Veterinary Pain Medication Price (US$/unit) by Application (2021-2032) Figure 71. Veterinary Pain Medication Value Chain Figure 72. Veterinary Pain Medication Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Veterinary Pain Medication Industry Opportunities and Challenges

Scope & coverage.

Types
  • Injection Medicines
  • Oral Medicines
Applications
  • Veterinary Hospitals
  • Veterinary Clinics
  • Others
Companies covered
  • Zoetis
  • Ringpu Bio-technology
  • Ruicheng Lvman Biological Pharmaceutical Co., Ltd.
  • Merck & Co
  • Medtronic
  • Lilly
  • Pfizer
  • Harbin Bolai Pharmaceutical Co., Ltd.
  • Bostonscientific
  • Bayer Pharma AG
  • Baxter
  • Norbrook Laboratories
  • Halyard
  • Forest Laboratories
  • Endo International
  • Elanco
  • Ceva Sante Animale
  • Boehringer Ingelheim

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Veterinary Pain Medication Market Size (2021-2032)
  4. 2.2.2 Global Veterinary Pain Medication Sales (2021-2032)
  5. 2.2.3 Global Veterinary Pain Medication Market Average Price (2021-2032)
  6. 2.3 Veterinary Pain Medication by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Injection Medicines
  9. 2.3.3 Oral Medicines
  10. 2.4 Veterinary Pain Medication by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Veterinary Hospitals
  13. 2.4.3 Veterinary Clinics
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Veterinary Pain Medication Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Veterinary Pain Medication Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Veterinary Pain Medication Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Veterinary Pain Medication Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Veterinary Pain Medication Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Veterinary Pain Medication, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Veterinary Pain Medication, Product Type & Application
  8. 3.8 Global Manufacturers of Veterinary Pain Medication, Established Date
  9. 3.9 Global Veterinary Pain Medication Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zoetis
  2. 4.1.1 Zoetis Company Information
  3. 4.1.2 Zoetis Business Overview
  4. 4.1.3 Zoetis Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zoetis Veterinary Pain Medication Product Portfolio
  6. 4.1.5 Zoetis Recent Developments
  7. 4.2 Ringpu Bio-technology
  8. 4.2.1 Ringpu Bio-technology Company Information
  9. 4.2.2 Ringpu Bio-technology Business Overview
  10. 4.2.3 Ringpu Bio-technology Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Ringpu Bio-technology Veterinary Pain Medication Product Portfolio
  12. 4.2.5 Ringpu Bio-technology Recent Developments
  13. 4.3 Ruicheng Lvman Biological Pharmaceutical Co., Ltd.
  14. 4.3.1 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Company Information
  15. 4.3.2 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Business Overview
  16. 4.3.3 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio
  18. 4.3.5 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Recent Developments
  19. 4.4 Merck & Co
  20. 4.4.1 Merck & Co Company Information
  21. 4.4.2 Merck & Co Business Overview
  22. 4.4.3 Merck & Co Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Merck & Co Veterinary Pain Medication Product Portfolio
  24. 4.4.5 Merck & Co Recent Developments
  25. 4.5 Medtronic
  26. 4.5.1 Medtronic Company Information
  27. 4.5.2 Medtronic Business Overview
  28. 4.5.3 Medtronic Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Medtronic Veterinary Pain Medication Product Portfolio
  30. 4.5.5 Medtronic Recent Developments
  31. 4.6 Lilly
  32. 4.6.1 Lilly Company Information
  33. 4.6.2 Lilly Business Overview
  34. 4.6.3 Lilly Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Lilly Veterinary Pain Medication Product Portfolio
  36. 4.6.5 Lilly Recent Developments
  37. 4.7 Pfizer
  38. 4.7.1 Pfizer Company Information
  39. 4.7.2 Pfizer Business Overview
  40. 4.7.3 Pfizer Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Pfizer Veterinary Pain Medication Product Portfolio
  42. 4.7.5 Pfizer Recent Developments
  43. 4.8 Harbin Bolai Pharmaceutical Co., Ltd.
  44. 4.8.1 Harbin Bolai Pharmaceutical Co., Ltd. Company Information
  45. 4.8.2 Harbin Bolai Pharmaceutical Co., Ltd. Business Overview
  46. 4.8.3 Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio
  48. 4.8.5 Harbin Bolai Pharmaceutical Co., Ltd. Recent Developments
  49. 4.9 Bostonscientific
  50. 4.9.1 Bostonscientific Company Information
  51. 4.9.2 Bostonscientific Business Overview
  52. 4.9.3 Bostonscientific Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Bostonscientific Veterinary Pain Medication Product Portfolio
  54. 4.9.5 Bostonscientific Recent Developments
  55. 4.10 Bayer Pharma AG
  56. 4.10.1 Bayer Pharma AG Company Information
  57. 4.10.2 Bayer Pharma AG Business Overview
  58. 4.10.3 Bayer Pharma AG Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Bayer Pharma AG Veterinary Pain Medication Product Portfolio
  60. 4.10.5 Bayer Pharma AG Recent Developments
  61. 4.11 Baxter
  62. 4.11.1 Baxter Company Information
  63. 4.11.2 Baxter Business Overview
  64. 4.11.3 Baxter Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Baxter Veterinary Pain Medication Product Portfolio
  66. 4.11.5 Baxter Recent Developments
  67. 4.12 Norbrook Laboratories
  68. 4.12.1 Norbrook Laboratories Company Information
  69. 4.12.2 Norbrook Laboratories Business Overview
  70. 4.12.3 Norbrook Laboratories Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Norbrook Laboratories Veterinary Pain Medication Product Portfolio
  72. 4.12.5 Norbrook Laboratories Recent Developments
  73. 4.13 Halyard
  74. 4.13.1 Halyard Company Information
  75. 4.13.2 Halyard Business Overview
  76. 4.13.3 Halyard Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Halyard Veterinary Pain Medication Product Portfolio
  78. 4.13.5 Halyard Recent Developments
  79. 4.14 Forest Laboratories
  80. 4.14.1 Forest Laboratories Company Information
  81. 4.14.2 Forest Laboratories Business Overview
  82. 4.14.3 Forest Laboratories Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Forest Laboratories Veterinary Pain Medication Product Portfolio
  84. 4.14.5 Forest Laboratories Recent Developments
  85. 4.15 Endo International
  86. 4.15.1 Endo International Company Information
  87. 4.15.2 Endo International Business Overview
  88. 4.15.3 Endo International Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Endo International Veterinary Pain Medication Product Portfolio
  90. 4.15.5 Endo International Recent Developments
  91. 4.16 Elanco
  92. 4.16.1 Elanco Company Information
  93. 4.16.2 Elanco Business Overview
  94. 4.16.3 Elanco Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Elanco Veterinary Pain Medication Product Portfolio
  96. 4.16.5 Elanco Recent Developments
  97. 4.17 Ceva Sante Animale
  98. 4.17.1 Ceva Sante Animale Company Information
  99. 4.17.2 Ceva Sante Animale Business Overview
  100. 4.17.3 Ceva Sante Animale Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Ceva Sante Animale Veterinary Pain Medication Product Portfolio
  102. 4.17.5 Ceva Sante Animale Recent Developments
  103. 4.18 Boehringer Ingelheim
  104. 4.18.1 Boehringer Ingelheim Company Information
  105. 4.18.2 Boehringer Ingelheim Business Overview
  106. 4.18.3 Boehringer Ingelheim Veterinary Pain Medication Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Boehringer Ingelheim Veterinary Pain Medication Product Portfolio
  108. 4.18.5 Boehringer Ingelheim Recent Developments
5 Global Veterinary Pain Medication Market Scenario by Region
  1. 5.1 Global Veterinary Pain Medication Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Veterinary Pain Medication Sales by Region: 2021-2032
  3. 5.2.1 Global Veterinary Pain Medication Sales by Region: 2021-2026
  4. 5.2.2 Global Veterinary Pain Medication Sales by Region: 2027-2032
  5. 5.3 Global Veterinary Pain Medication Revenue by Region: 2021-2032
  6. 5.3.1 Global Veterinary Pain Medication Revenue by Region: 2021-2026
  7. 5.3.2 Global Veterinary Pain Medication Revenue by Region: 2027-2032
  8. 5.4 North America Veterinary Pain Medication Market Facts & Figures by Country
  9. 5.4.1 North America Veterinary Pain Medication Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Veterinary Pain Medication Sales by Country (2021-2032)
  11. 5.4.3 North America Veterinary Pain Medication Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Veterinary Pain Medication Market Facts & Figures by Country
  16. 5.5.1 Europe Veterinary Pain Medication Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Veterinary Pain Medication Sales by Country (2021-2032)
  18. 5.5.3 Europe Veterinary Pain Medication Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Veterinary Pain Medication Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Veterinary Pain Medication Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Veterinary Pain Medication Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Veterinary Pain Medication Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Veterinary Pain Medication Market Facts & Figures by Country
  41. 5.7.1 South America Veterinary Pain Medication Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Veterinary Pain Medication Sales by Country (2021-2032)
  43. 5.7.3 South America Veterinary Pain Medication Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Veterinary Pain Medication Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Veterinary Pain Medication Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Veterinary Pain Medication Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Veterinary Pain Medication Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Veterinary Pain Medication Sales by Type (2021-2032)
  2. 6.1.1 Global Veterinary Pain Medication Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Veterinary Pain Medication Sales Market Share by Type (2021-2032)
  4. 6.2 Global Veterinary Pain Medication Revenue by Type (2021-2032)
  5. 6.2.1 Global Veterinary Pain Medication Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Veterinary Pain Medication Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Veterinary Pain Medication Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Veterinary Pain Medication Sales by Application (2021-2032)
  2. 7.1.1 Global Veterinary Pain Medication Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Veterinary Pain Medication Sales Market Share by Application (2021-2032)
  4. 7.2 Global Veterinary Pain Medication Revenue by Application (2021-2032)
  5. 7.2.1 Global Veterinary Pain Medication Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Veterinary Pain Medication Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Veterinary Pain Medication Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Veterinary Pain Medication Value Chain Analysis
  2. 8.1.1 Veterinary Pain Medication Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Veterinary Pain Medication Production Mode & Process
  5. 8.2 Veterinary Pain Medication Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Veterinary Pain Medication Distributors
  8. 8.2.3 Veterinary Pain Medication Customers
9 Global Veterinary Pain Medication Analyzing Market Dynamics
  1. 9.1 Veterinary Pain Medication Industry Trends
  2. 9.2 Veterinary Pain Medication Industry Drivers
  3. 9.3 Veterinary Pain Medication Industry Opportunities and Challenges
  4. 9.4 Veterinary Pain Medication Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst